Choksi Laboratories Limited provides contract testing and analytical services in India and internationally.
Imperfect balance sheet and overvalued.
Share Price & News
How has Choksi Laboratories's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 526546's share price has been volatile over the past 3 months.
7 Day Return
IN Professional Services
1 Year Return
IN Professional Services
Return vs Industry: 526546 underperformed the Indian Professional Services industry which returned 8.2% over the past year.
Return vs Market: 526546 underperformed the Indian Market which returned 9.5% over the past year.
Price Volatility Vs. Market
How volatile is Choksi Laboratories's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Choksi Laboratories undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: 526546 (₹9.61) is trading above our estimate of fair value (₹2.33)
Significantly Below Fair Value: 526546 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 526546 is unprofitable, so we can't compare its PE Ratio to the Professional Services industry average.
PE vs Market: 526546 is unprofitable, so we can't compare its PE Ratio to the Indian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 526546's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 526546 is good value based on its PB Ratio (0.3x) compared to the IN Professional Services industry average (0.8x).
How is Choksi Laboratories forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Commercial Services industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Choksi Laboratories has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Take a look at our analysis of 526546’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- Choksi Laboratories competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Commercial Services industry.
How has Choksi Laboratories performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 526546 is currently unprofitable.
Growing Profit Margin: 526546 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: 526546 is unprofitable, but has reduced losses over the past 5 years at a rate of 4.7% per year.
Accelerating Growth: Unable to compare 526546's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 526546 is unprofitable, making it difficult to compare its past year earnings growth to the Professional Services industry (6.1%).
Return on Equity
High ROE: 526546 has a negative Return on Equity (-3.07%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
How is Choksi Laboratories's financial position?
Financial Position Analysis
Short Term Liabilities: 526546's short term assets (₹166.7M) exceed its short term liabilities (₹115.0M).
Long Term Liabilities: 526546's short term assets (₹166.7M) do not cover its long term liabilities (₹243.3M).
Debt to Equity History and Analysis
Debt Level: 526546's debt to equity ratio (97.7%) is considered high.
Reducing Debt: 526546's debt to equity ratio has increased from 44% to 97.7% over the past 5 years.
Inventory Level: 526546 has a high level of physical assets or inventory.
Debt Coverage by Assets: 526546's debt is not covered by short term assets (assets are 0.7x debt).
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 526546 has been profitable on average in the past, therefore cash runway is not a concern.
Forecast Cash Runway: Insufficient data to determine if 526546 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is Choksi Laboratories's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate 526546's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate 526546's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 526546's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 526546's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 526546's dividend in 3 years as they are not forecast to pay a notable one for the Indian market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Sunil Choksi (64yo)
Mr. Sunil Kumar Choksi serves as the Chief Executive Officer, Chairman and Managing Director at Choksi Laboratories Ltd and has been its Executive Director since September 01, 2008.
CEO Compensation Analysis
Compensation vs Market: Sunil's total compensation ($USD55.13K) is about average for companies of similar size in the Indian market ($USD50.06K).
Compensation vs Earnings: Sunil's compensation has increased whilst the company is unprofitable.
|CEO, MD & Executive Chairman||0yrs||₹3.96m||13.25% ₹8.9m|
|CFO & Whole-Time Director||15.5yrs||₹2.64m||6.42% ₹4.3m|
|COO & Whole Time Director||3.9yrs||₹2.58m||0.014% ₹9.6k|
|Whole-Time Director||26.4yrs||₹2.59m||3.16% ₹2.1m|
|Independent Non-Executive Director||21.1yrs||₹32.00k||0.0057% ₹3.8k|
|Independent Non-Executive Director||10.3yrs||₹30.00k||no data|
|Independent Additional Director||1.8yrs||no data||no data|
|Independent Non-Executive Director||1.8yrs||no data||no data|
Experienced Board: 526546's board of directors are seasoned and experienced ( 10.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Choksi Laboratories Limited's company bio, employee growth, exchange listings and data sources
- Name: Choksi Laboratories Limited
- Ticker: 526546
- Exchange: BSE
- Founded: 1982
- Industry: Research and Consulting Services
- Sector: Commercial Services
- Market Cap: ₹66.936m
- Shares outstanding: 6.97m
- Website: https://www.choksilab.com
Number of Employees
- Choksi Laboratories Limited
- 6/3 Manoramaganj
- Madhya Pradesh
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|526546||BSE (Mumbai Stock Exchange)||Yes||Equity Shares||IN||INR||May 2005|
Choksi Laboratories Limited provides contract testing and analytical services in India and internationally. The company's contract laboratory services include pharmaceutical, food and beverages, water, and construction material analysis. Its instrument calibration and validation services comprise laboratory and on-site calibration for test equipment, process equipment, and various end-user equipment; plant shutdown calibration; and consultancy for setting up an in-house calibration laboratory. The company also offers environment management, laboratory, waste water management, and air pollution monitoring services. In addition, it provides clinical research services, such as bio-availability and bio-equivalence studies; and consultancy and allied services consisting of training, third-party inspection, auditing, laboratory set-up and management, and environment management services. Further, the company offers assaying and hallmarking services for gold and silver. It primarily serves the pharmaceuticals, consumer products, and engineering sectors. Choksi Laboratories Limited was founded in 1982 and is based in Indore, India.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/24 12:35|
|End of Day Share Price||2020/02/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.